孕产妇的肥胖会减少后代的寿命
bioRxiv : the preprint server for biology
|February 12, 2026
概括
孕产妇的肥胖大大缩短了后代的寿命,并增加了与年龄有关的疾病. 这些与早期发育变化相关的有害影响,即使在断奶后继续健康饮食,也会影响长寿.
科学领域:
- 发展生物学 发展生物学
- 老年学是一门学科.
- 生殖健康 生殖健康
背景情况:
- 孕产妇的肥胖与后代的疾病风险增加有关.
- 产妇肥胖对后代的长期衰老影响尚不清楚.
研究的目的:
- 调查母亲肥胖对后代寿命和与年龄相关的病理学的影响.
- 为了确定早期暴露于孕产妇肥胖是否对衰老有持久的影响.
主要方法:
- 研究了来自肥胖母亲的小鼠.
- 监测了寿命,并评估了与年龄相关的器官纤维化病理.
- 使用Gompertz分析来分析寿命数据.
主要成果:
- 孕产妇的肥胖显著减少了男性和女性后代的寿命.
- 寿命缩短与肝脏,心脏和脏纤维化病理增加有关.
- 戈珀茨的分析表明,寿命缩短是由于早期发育变化.
结论:
- 孕产妇的肥胖对后代的长寿和健康有不利的长期影响.
- 通过母亲肥胖的早期发育编程,而不是以后的衰老因素,导致寿命缩短.
- 孕产妇肥胖率的上升可能会缩短后代的寿命,并增加与年龄相关的疾病.
更多相关视频
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
11.9K
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
2.4K
相关概念视频
Decreasing Function
312
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2 in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
312
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Decreased Body Temperature
1.1K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Decreased pulse rate
933
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
933
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
296
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
296
